Filing Details

Accession Number:
0001144204-11-032494
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-25 22:25:10
Reporting Period:
2011-05-17
Filing Date:
2011-05-25
Accepted Time:
2011-05-25 21:25:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326190 Pharmathene Inc PIP Pharmaceutical Preparations (2834) 202726770
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1409487 D Valerie Riddle C/O Pharmathene, Inc.
One Park Place, Suite 450
Annapolis MD 21401
Svp, Medical Director No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.0001 Par Value Per Share Acquisiton 2011-05-23 3,438 $2.46 56,761 No 4 M Direct
Common Stock, $0.0001 Par Value Per Share Disposition 2011-05-23 3,438 $3.68 53,323 No 4 S Direct
Common Stock, $0.0001 Par Value Per Share Disposition 2011-05-23 5,353 $3.63 49,790 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to purchase Disposition 2011-05-23 3,438 $0.00 3,438 $2.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
24,065 2019-01-21 No 4 M Direct
Footnotes
  1. The transactions reported hereon have been effected pursuant to the Reporting Person's 10b5-1 Plan.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.628 to $3.633, inclusive.
  3. The option exercised is part of a January 21, 2009 grant of options to purchase an aggregate of 27,503 shares, which vests over a 4 year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant date.